BenQ Medical Technology - Asset Resilience Ratio
BenQ Medical Technology (4116) has an Asset Resilience Ratio of 4.75% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how BenQ Medical Technology's Asset Resilience Ratio has changed over time. Check strategic asset allocation of BenQ Medical Technology to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down BenQ Medical Technology's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BenQ Medical Technology market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$250.09 Million | 4.75% |
| Total Liquid Assets | NT$250.09 Million | 4.75% |
Asset Resilience Insights
- Limited Liquidity: BenQ Medical Technology maintains only 4.75% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
BenQ Medical Technology Industry Peers by Asset Resilience Ratio
Compare BenQ Medical Technology's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.46% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for BenQ Medical Technology (2017–2024)
The table below shows the annual Asset Resilience Ratio data for BenQ Medical Technology.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.24% | NT$328.98 Million ≈ $10.36 Million |
NT$5.27 Billion ≈ $166.15 Million |
-1.55pp |
| 2023-12-31 | 7.79% | NT$366.87 Million ≈ $11.56 Million |
NT$4.71 Billion ≈ $148.46 Million |
+2.13pp |
| 2022-12-31 | 5.66% | NT$192.20 Million ≈ $6.06 Million |
NT$3.40 Billion ≈ $107.06 Million |
+3.03pp |
| 2021-12-31 | 2.63% | NT$51.42 Million ≈ $1.62 Million |
NT$1.96 Billion ≈ $61.60 Million |
-2.30pp |
| 2020-12-31 | 4.93% | NT$88.43 Million ≈ $2.79 Million |
NT$1.79 Billion ≈ $56.55 Million |
+1.78pp |
| 2019-12-31 | 3.15% | NT$53.27 Million ≈ $1.68 Million |
NT$1.69 Billion ≈ $53.28 Million |
-0.44pp |
| 2018-12-31 | 3.59% | NT$60.44 Million ≈ $1.90 Million |
NT$1.68 Billion ≈ $52.98 Million |
-0.37pp |
| 2017-12-31 | 3.97% | NT$61.24 Million ≈ $1.93 Million |
NT$1.54 Billion ≈ $48.62 Million |
-- |
About BenQ Medical Technology
BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the… Read more